Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Breast Cancer Res Treat. 2012 Dec 6;137(2):449–455. doi: 10.1007/s10549-012-2366-0

Figure 2.

Figure 2

Adjusted competing risk model log hazard ratio function (LHRF) estimates for HER2 status (positive vs. negative) according to HR status, year since diagnosis, and site of recurrence. Red curves are for HR negative patients and green curves are for HR positive patients. Solid lines are point estimates and dashed lines are corresponding 95% confidence intervals.